explore -WSS

explore

author：knowledge 2025-10-03 00:22:41 - browse：9

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

A California biotech developing a combination therapy with the obesity drug Zepbound has raised a $170 million Series D round.

The company, BioAge, raised money from more than a dozen investors. Sofinnova Investments led the round, which also included Eli Lilly and Amgen’s venture arms and previous investor Andreessen Horowitz.

BioAge’s primary focus is in developing medications that boost a person’s healthspan, or the number of healthy years a person lives. The company has drugs in development for neuroinflammation and brain aging. But the majority of the Series D proceeds will be used to develop the company’s lead drug candidate azelaprag, which is being tested in combination with Zepbound. That drug program is what grabbed Sofinnova’s attention, according to managing partner Jim Healy, who recently became chairman of BioAge’s board.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FDA seeking to stop procedures at two unregulated stem cell clinics

WSS

15 die by electrocution after transformer explodes in northern India

After gene therapy, two congenitally deaf children hear for the first time

Study: Hearing aids may slow cognitive decline in those at risk

FDA seeking to stop procedures at two unregulated stem cell clinics

Study: Hearing aids may slow cognitive decline in those at risk

What we know about the American soldier detained in North Korea

explore

explore

Wikipedia

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Flagship, Pfizer team up in deal worth up to $7 billion

Medicare proposal to cover medical devices draws a mixed reaction

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

15 die by electrocution after transformer explodes in northern India

Heart attack and stroke risk calculators need revising

ER docs worry over extreme heat as a 'mass casualty event'

How one medical school became remarkably diverse

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

hotspot

What nurses really want: sufficient staffing for patient care

Lack of darker skin in textbooks, journals harms patients of color

First recipient of genetically engineered pig kidney has died

What we know about the American soldier detained in North Korea

A Theranos scientist

Why you get paid to donate plasma but not blood

leisure time

focus

hotspot

explore